We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NeuroVive

News List

NeuroVive to continue NeuroSTAT clinical development pharmaasia
June 06, 2017
The positive outcome from the clinical phase IIa CHIC study and the preclinical studies have now convinced NeuroVive to proceed into the next stage of clinical development.
NeuroVive in partnership with Yungjin Pharm Corporation Ltd biospectrumasia
May 03, 2017
NeuroVive Pharmaceutical AB and Yungjin Pharm Corporation Ltd jointly announced that they have entered into a global licensing agreement on Yungjin Pharm's compound KL1333 for genetic mitochondrial disorders.
Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) en-cphi.cn
April 01, 2017
NeuroVive Pharmaceutical AB announced an increase of the number of shares and votes in NeuroVive of 23,328. This is a result of a performed subscription options program (series 2016/2017:1).
NeuroVive Signs Collaboration Agreement with Karolinska Institutet americanpharmaceuticalreview
January 11, 2017
NeuroVive Pharmaceutical announced that a collaboration agreement has been signed with Karolinska Institutet, Stockholm, Sweden, regarding development of the company's compound NV556 for the treatment of mitochondrial myopathy.

Previous page 1 2 Next page